fluoxetine and fluvoxamine

fluoxetine has been researched along with fluvoxamine in 295 studies

Research

Studies (295)

TimeframeStudies, this research(%)All Research%
pre-199012 (4.07)18.7374
1990's130 (44.07)18.2507
2000's90 (30.51)29.6817
2010's45 (15.25)24.3611
2020's18 (6.10)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA1
Dormann, SM; Haefeli, WE; Kerpen, CJ; Ketabi-Kiyanvash, N; Martin-Facklam, M; Weiss, J1
Dansette, PM; Fontana, E; Poli, SM1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Glen, RC; Lowe, R; Mitchell, JB1
Ekins, S; Williams, AJ; Xu, JJ1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F1
Freiwald, S; Jiang, Y; Jones, JP; Kaspera, R; Katayama, J; Lee, CA; Smith, E; Totah, RA; Walker, GS1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Qin, W; Tian, S; Wold, EA; Xu, Q; Ye, N; Zhen, XC; Zhou, J1
Bojarski, AJ; Bugno, R; Duszyńska, B; Hogendorf, A; Hogendorf, AS; Kurczab, R; Lenda, T; Pietruś, W; Satała, G; Staroń, J; Wantuch, A; Warszycki, D1
Karsch, V; Starke, K; Szabo, B1
Anthony, DT; Fallon, BA; Hollander, E; Klein, DF; Liebowitz, MR; Schneier, FR; Stein, DJ1
Crewe, HK; Haddock, RE; Lennard, MS; Tucker, GT; Woods, FR1
Carrasco, JL; Hollander, E; Liebowitz, MR; Schneier, FR1
Baumann, P; Bertschy, G; Bizouard, P; Bonin, B; Bouquet, S; Francois, T; Sechter, D; Vandel, S; Volmat, R1
Bertschy, G; Bizouard, P; Bonin, B; Bouquet, S; Sechter, D; Vandel, B; Vandel, S1
Goodman, WK; McDougle, CJ; Price, LH3
Kindler, S; Zohar, J1
Corrigan, FM1
Kaspi, N; Sirota, P1
DeVane, CL1
Johnson, AM; Tulloch, IF1
March, JS1
Kapur, S; Mann, JJ1
Brockmöller, J; Müller, N; Roots, I1
George, MS1
Baldwin, D; Bullock, T; Montgomery, D; Montgomery, S1
Guimaraes, FS1
Baldwin, D; Fineberg, N; Montgomery, S1
Mavissakalian, MR; Tamimi, RR1
DeCaria, CM; Hollander, E; Klein, DF; Liebowitz, MR; Schneier, FR; Schneier, HA1
DeCaria, C; Fairbanks, J; Fallon, B; Hollander, E; Klein, DF; Liebowitz, MR1
Insel, TR1
Hoehn-Saric, R; Lipsey, JR; McLeod, DR1
Baer, L; Buttolph, L; Holland, A; Hyman, S; Jenike, MA; Minichiello, WE; Ricciardi, J; Seymour, R; Summergrad, P1
Greist, JH; Johnston, H; March, JS1
Fuller, RW1
Asberg, M; Eriksson, B; Mårtensson, B; Träskman-Bendz, L; Wägner, A1
Mendels, J1
Netter, P1
Cole, JO; Dessain, E; Katz, DL; O'Neil, P; Schatzberg, AF1
Durcan, MJ; Eckardt, MJ; Linnoila, M; Lister, RG2
Harms, HH1
Bymaster, FP; Reid, LR; Threlkeld, PG; Wong, DT1
Maj, J; Rogóz, Z; Skuza, G; Sowińska, H1
Baumann, P; Rochat, B1
Anelli, M; Caccia, S; Codegoni, AM; Fracasso, C; Garattini, S1
Finley, PR1
Hyttel, J; Sánchez, C1
Greist, JH; Jefferson, JW; Katzelnick, DJ; Kobak, KA; Serlin, RC1
Jordan, S; Kramer, GL; Moeller, M; Petty, F; Zukas, PK1
Conte, G; Guarneri, L; Sacchetti, E1
Carroll, BJ1
Bianchi, M; Panerai, AE; Sacerdote, P1
Dominguez, RA; Mestre, SM1
Edwards, JG; Inman, WH; Pearce, GL; Wilton, L1
Mattes, JA1
Brøsen, K2
Jackson, CW; Lydiard, RB; Morton, WA1
Fux, M; Taub, M; Zohar, J1
Glancy, GD1
Avenoso, A; Caputi, AP; Fazio, A; Pisani, F; Pollicino, AM; Spina, E1
Joffe, RT; Schuller, DR1
Bellodi, L; Mundo, E; Ronchi, P1
Alhaider, AA; Mustafa, AA1
de Koning, GH; Ottervanger, JP; Stricker, BH; van den Bemt, PM1
Eagles, JM; Parkin, JR1
Rasker, MC1
LaBranche, S1
Brieaddy, L; Cooper, B; Ferris, RM; Hollingsworth, E; Mehta, N; Rigdon, G; Soroko, F; Wang, C; Wastila, W1
Joffe, RT; Levitt, AJ; Sokolov, ST; Young, LT1
Newhouse, PA1
Aizenberg, D; Weizman, A; Zemishlany, Z1
Baumann, P; Bertschy, G; Bizouard, P; Bonin, B; Bouquet, S; Francois, T; Sechter, D; Vandel, S1
Knowles, SR; Liu, BA; Mittmann, N; Shear, NH1
Artigas, F; Bel, N1
Harvey, AT; Preskorn, SH2
Baumann, P; Eap, CB; Gaillard, N; Powell, K1
Brøsen, K; Gram, LF; Jeppesen, U; Loft, S; Poulsen, HE; Vistisen, K1
Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH1
Baumann, P; Bertschy, G; Eap, CB; Powell, K2
Bradford, D; Coccaro, E; Fabre, L; Holland, P; Perse, T; Rapaport, M; Sheline, Y1
Catalano, M; Lucca, A; Lucini, V; Smeraldi, E1
Leo, RJ1
Harnett-Sheehan, K; Sheehan, DV1
Iancu, I; Kindler, S; Sasson, Y; Weizman, A; Zohar, J1
de Vet, HC; Hartmans, M; Honig, A; Menting, JE; Rozendaal, N; van Praag, HM; Verhey, FR1
Kurz, X; Ottervanger, JP; Roisin, T; Stricker, BH; Van Ermen, AM1
Barzega, G; Bellino, S; Bogetto, F; Maina, G; Ravizza, L1
Preskorn, SH1
Brown, J; Del Boca, FK; Korner, PF; Kranzler, HR1
Baumann, P; Eap, CB1
MacKay, AV; Price, JS; Waller, PC; Wood, SM1
Bradford, JM; Curry, S; Greenberg, DM; O'Rourke, A1
Bardgett, ME; Csernansky, JG; Sheline, Y1
Meier, E; Sánchez, C1
Dager, SR; Hayes, CE; Layton, ME; Strauss, WL1
Earley, B; Faherty, CJ; Leonard, BE1
Dannon, PN; Iancu, I; Kindler, S; Sasson, Y; Zohar, J1
Black, KJ; Sheline, YI1
Alamo, C; Carvajal, A; Hervás, J; Velasco, A1
Bourin, M; Redrobe, JP2
Baldessarini, RJ; Bodkin, JA; Gardner, DM; Lasser, RA; Wines, JD1
Ahern, D; Ball, SE; Kao, J; Scatina, J1
Lopukhov, IG1
Klenk-Majewska, B; Lupina, T; Ossowska, G; Pietrasiewicz, T; Zebrowska-Lupina, I1
den Boer, JA1
Mitchell, S; Tracy, KA; Zajecka, J1
Anand, A; Barr, LC; Goodman, WK; McDougle, CJ; Price, LH1
Bousoño, M; Calcedo, A; Carrasco, JL; Ciudad, J; Daniel, E; De la Gandara, J; Derecho, J; Franco, M; Gomez, MJ; Izquierdo, JA; Ledesma, A; Llorca, G; Macias, JA; Martin, T; Montejo-González, AL; Perez, V; Sanchez, JM; Sanchez, S; Vicens, E1
Richelson, E2
Bisserbe, JC; Flament, MF1
Gorman, JM1
Costa, E; Davis, JM; Guidotti, A; Rasmusson, A; Sheline, Y; Uzunov, DP; Uzunova, V1
Fundaró, A1
Berthou, F; Dréano, Y; Iribarne, C; Picart, D1
Mazo, GE; Razorenov, GI; Razorenova, TS; Vovin, RIa1
Dirksen, R; Van Luijtelaar, EL; Van Rijn, CM1
Belpaire, FM; Brøsen, K; Rasmussen, BB; Temmerman, A; Wijnant, P1
Hengeveld, MW; Olivier, B; Waldinger, MD; Zwinderman, AH1
Barbey, JT; Roose, SP1
Cheriex, EC; Honig, A; Lousberg, R; Strik, JJ; Van Praag, HM1
Berendsen, HH; Bouwknecht, JA; Broekkamp, CL; Gommans, J; Hijzen, TH; Maes, RA; Olivier, B1
Stahl, SM1
Goudemand, M; Rousseaux, M; Thomas, P1
Coccaro, EF; Hauger, RL; Kavoussi, RJ1
Alvarez, E; Artigas, F; Pérez, V; Puigdemont, D; Soler, J1
Alfaro, CL; Ereshefsky, L; Lam, YW; Simpson, J1
Meyers, BS1
De Vry, J; Maurel, S; Schreiber, R1
Deslandes, A; Magariños, AM; McEwen, BS1
Epperson, CN; Fasula, D; McDougle, CJ; Price, LH; Wasylink, S1
Daniel, WA; Haduch, A; Syrek, M; Wójcikowski, J2
Baer, L; Jenike, MA; Manzo, PA; Mataix-Cols, D; Rauch, SL1
Carleborg, L; Hägg, S; Ohman, R; Spigset, O1
Sheehan, DV1
Gorfinkle, KS; Liebowitz, MR; Simpson, HB1
Inoue, K; Sugimoto, Y; Yamada, J1
Churchill, E; Davidson, JR; Meltzer-Brody, S1
Härtter, S; Hiemke, C1
Borgeat, F; Freeston, MH; Todorov, C1
Aguas Nuevo, E; Berzas Nevado, JJ; Contento Salcedo, AM; Villaseñor Llerena, MJ1
Gentilini, G; Lopez-Silva, S; Lucca, A; Soldarini, A1
Mielech, K; Starczewska, B1
Baranowska, K; Puzanowska-Tarasiewicz, H; Starczewska, B1
Baier, D; Kohnen, R; Philipp, M; Tiller, JW1
Bolo, NR; Hodé, Y; Lainé, E; Macher, JP; Nédélec, JF; Wagner, G1
Court, MH; Duan, SX; Greenblatt, DJ; Hesse, LM; Shader, RI; Venkatakrishnan, K; von Moltke, LL1
Buzinkaiová, T; Polonský, J1
Norrholm, SD; Ouimet, CC1
Woods, SW1
Fitzgerald, F; Glod, CA; Lynch, A1
Dewa, CS; Goering, P; Hoch, JS1
Grewal, A; Lam, RW; Lee, SK; Tam, EM; Yatham, LN1
Baba, J; Fujishiro, J; Imanishi, T; Kosaka, K1
Apter, A; Kohn, Y; Weizman, A1
Bergsholm, YK; Bøhler, E; Nordeng, H; Spigset, O1
Alonso, P; Mataix-Cols, D; Menchon, JM; Pifarre, J; Salgado, P; Torres, L; Vallejo, J1
Camarero, J; Colado, MI; Esteban, B; Green, AR; Peter, MJ; Sanchez, V1
Knoke, DM; Naranjo, CA1
Dratcu, L1
Cowan, C; Dager, SR; Dawson, G; Strauss, WL; Unis, AS1
Cullen, N; Lexell, J; Zafonte, RD1
Hashimoto, S; Hattori, T; Kawasaki, K; Kitamura, Y; Miki, N; Mochizuki, D; Otsuka, Y; Tsujita, R; Yamada, S1
Alfaro, CL; Ereshefsky, L; Gaedigk, A; Lam, YW; Simpson, J1
Caffieri, S; Giusti, P; Imbesi, M; Levorato, L; Manev, H; Manev, R; Miolo, G; Uz, T1
Abikoff, H; Bergman, RL; Davies, M; Fairbanks, J; Gammon, P; Greenhill, L; Hack, S; Klee, B; Klein, R; Labellarte, M; Lynn, D; March, J; McCracken, J; Pine, DS; Riddle, MA; Ritz, L; Roper, M; Sweeney, M; Vitiello, B; Walkup, J1
Sugimoto, Y; Yamada, J1
Entsuah, R; Rudolph, RL; Stahl, SM1
Anderson, TA; Dobscha, SK; Hauser, P; Hoffman, WF; Snodgrass, LS; Turner, EH; Winterbottom, LM1
Bubar, MJ; Cunningham, KA; De Deurwaerdère, P; McMahon, LR; Spampinato, U1
Baba, J; Fujiwara-Sawada, M; Imanishi, T; Yoshida, A1
Ikeda, K; Kobayashi, T; Washiyama, K1
Białous, B; Jasińska, A; Starczewska, B1
Dalery, J; Honig, A1
Kamei, J; Miyata, S; Morita, K; Saitoh, A; Takeda, H1
Bocchetta, A; Del Zompo, M; Martinelli, V; Palmas, AM1
Alfaro, CL; Ereshefsky, L; Lam, YW; Miller, M1
Broocks, A; Hohagen, F; Kordon, A1
Anderson, GM; Dodson, AM; Rhoden, KJ1
Masuda, Y; Shimizu, T1
Bolo, NR; Hodé, Y; Macher, JP1
Eichner, SF; Jones, JR; Moore, ML1
Casciano, R; Chen, J; Geissler, EC; Mallick, R; Panish, JM; Trivedi, MH; Wan, GJ1
Armbrust, KL; Black, MC; Henry, TB; Kwon, JW1
Hirano, K; Kagawa, Y; Kimura, R; Maruyama, S; Yamada, S1
Silver, H1
Albert, U; Bogetto, F; Maina, G; Salvi, V1
Atmaca, S; Baktr, G; Cetin, SM; Ersoy, L; Ertürk, S1
Hashimoto, H; Hirano, K; Kato, Y; Kimura, R; Sugimoto, Y; Uchida, S; Yamada, J; Yamada, S1
Fontenelle, LF; Mendlowicz, MV; Versiani, M1
Amireault, P; Dubé, F1
Sharma, S; Tandon, R; Trivedi, JK1
Bader, M; Lookingland, K; Murphy, DL; Ni, W; Watts, SW; Wilhelm, CS1
Cela, R; Garcia-Jares, C; Lamas, JP; Llompart, M; Salgado-Petinal, C1
Bestari, KJ; Brain, RA; Johnson, DJ; Sanderson, H; Solomon, KR; Wilson, CJ1
Dinca, O; Paul, M; Spencer, NJ1
Carrasco, JL; Sandner, C1
Furumoto, M; Haito, S; Ito, M; Kawai, Y; Miyamoto, K; Terao, J1
Pick, CG; Schreiber, S1
Gupta, G; Kumar, VS; Maikhuri, JP; Sharma, VL; Singh, D; Singh, MM; Tiwari, P1
Anderson, SW; Booker, MB1
Berger, U; Jensen, E; Kallenborn, R; Samuelsen, PJ; Vasskog, T1
Brain, RA; Johnson, DJ; Sanderson, H; Solomon, KR; Wilson, CJ1
Belmaker, RH; Nemets, B; Shapira, B; Trachtenberg, A1
Bailly, D1
Baraldi, C; Bassi, T; Bellodi, L; Cavedini, P; Gorini, A; Ubbiali, A; Zorzi, C1
Bazinet, RP; Chang, L; Ertley, RN; Lee, HJ; Rao, JS; Rapoport, SI1
Hallifax, D; Houston, JB1
Brown, HS; Chadwick, A; Houston, JB1
Benattia, I; Demitrack, M; Entsuah, R; Nemeroff, CB; Sloan, DM; Thase, ME1
Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A1
Barton, R1
Olivier, B; Schweitzer, DH; Waldinger, MD; Zwinderman, AH1
Balayssac, S; Gilard, V; Malet-Martino, M; Martino, R; Trefi, S1
Aperi, J; Borenstein, J; Jones, JB; Karne, A; Shah, NR; Shemtov, R1
Hirano, K; Hotta, Y; Kajiwara, Y; Kobayashi, Y; Sugimoto, Y; Tagawa, N; Yamada, J; Yamada, S1
Ikonomidis, I; Kremastinos, DT; Lekakis, J; Moutsatsou, P; Nikolaou, M; Papoutsi, Z; Parissis, J1
Amitani, H; Asakawa, A; Fujimiya, M; Fujitsuka, N; Hayashi, M; Inui, A; Kojima, S; Sameshima, M1
Hasegawa, R; Ikeda, K; Karasawa, J; Tamura, K; Yamamoto, H; Yamamoto, T; Yasumoto, S1
Aburakawa, Y; Aizawa, H; Hasebe, N; Kwak, S; Sawada, J; Yamashita, T1
Bloch, MH; Coric, V; Dombrowski, P; Goodman, WK; Kelmendi, B; Krystal, JH; Landeros-Weisenberger, A; Leckman, JF; Nudel, J; Pittenger, C; Wegner, R1
Charles, D; Fava, M; Papakostas, GI1
Dormuth, CR; Lee, JC; Mehta, J; Miller, M; Patrick, AR; Schneeweiss, S; Solomon, DH; Wang, PS1
Dormuth, C; Lee, JC; Mehta, J; Miller, M; Patrick, AR; Schneeweiss, S; Solomon, DH; Wang, PS1
Nierenberg, AA; Schutte, AJ; Simmons, JH; Thase, ME; van Oers, HJ; Vrijland, P1
Mochcovitch, MD; Nardi, AE1
Antonioli, L; Blandizzi, C; Colucci, R; Corona, T; Fornai, M; Mantarro, S; Montagnani, S; Pergola, A; Ruggiero, E; Scollo, C; Testi, A; Tuccori, M1
Hazell, P; Silove, N; Wheeler, DM; Williams, K1
Dobzhenko, MN; Shchepotin, IB; Zotov, AS1
Cao, XH; Li, K; Lin, M; Shen, PC; Wang, HT; Wang, R; Xu, DF; Zheng, J1
Fallon, BA; Pavlicova, M; Schweitzer, PJ; Zafar, U1
Dasgupta, K; Labos, C; Nedjar, H; Rahme, E; Turecki, G1
Cavanna, AE; Rickards, H; Worrall, R1
Barata C, C; Campos, B; Piña, B1
Mandrioli, R; Mercolini, L; Raggi, MA; Saracino, MA1
Andrade, C2
Hidaka, H; Mitsutsuka, Y; Oyama, T; Serpone, N; Takamura, T; Tsukamoto, T1
Gorman, DA; Lam, D; Patten, S; Pringsheim, T1
Barata, C; Campos, B; Escalon, L; Garcia-Reyero, N; Habib, T; Piña, B; Rivetti, C; Tauler, R; Tsakovski, S1
Brignell, A; Hazell, P; Randall, M; Silove, N; Williams, K1
Hermann, M; Molden, E; Waade, RB1
Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N1
Banzi, R; Cusi, C; Moja, L; Randazzo, C; Sterzi, R; Tedesco, D1
Halling-Sørensen, B; Hansen, CH; Jacobsen, NW; Nellemann, C; Styrishave, B1
Delgermurun, D; Ito, S; Ohta, T; Otsuguro, K; Yamaguchi, S1
Bloch, MH; Freemantle, N; Jakubovski, E; Taylor, MJ; Varigonda, AL1
Ask, KS; Bardakci, T; Gjelstad, A; Halvorsen, TG; Parmer, MP; Pedersen-Bjergaard, S; Øiestad, EL1
Casavant, MJ; Chounthirath, T; Russell, JL; Spiller, HA1
Daws, LC; Koek, W; Sandoval, TL1
Drobniewska, A; Nałęcz-Jawecki, G; Sikorska, K; Wawryniuk, M1
Assimon, MM; Brookhart, MA; Flythe, JE1
Arnold, PD; Bousman, C; Greenslade, A; Maruf, AA1
Liao, XM; Si, TM; Su, YA; Wang, Y; Yu, X1
Hui, A1
Chen, L; Feng, X; Huang, C; Shen, X; Wang, J; Xu, T1
Aghaeepour, N; Maric, I; Oskotsky, B; Oskotsky, T; Sirota, M; Stevenson, DK; Tang, A; Wong, RJ1
Hoertel, N1
Komarov, SD; Severtsev, VV; Vdovin, AS; Vinnikova, MA1
Bálint, BL; Hermán, L; Mahdi, M; Réthelyi, JM1
Al-Khatib, SM; Assimon, MM; Brookhart, MA; Flythe, JE; Gaynes, BN; Pun, PH; Winkelmayer, WC1
da Rosa, TF; Foletto, VS; Hörner, R; Serafin, MB1
Azoulay, L; Cao, TXD; Fergusson, E; Filliter, C; Montastruc, F; Rej, S; Renoux, C; Yu, OHY1
Bayati, R; Ghaffari Jolfayi, A; Nakhaee, H; Rahmanian, M; Rakhshanderou, S; Zangiabadian, M1
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K1
Abbas, U; Deng, J; Garcia, C; Heybati, K; Huang, E; Moskalyk, M; Park, YJ; Ramaraju, HB; Rayner, D; Zhou, F1
Izumi, Y; Lenze, EJ; Mennerick, SJ; Reiersen, AM; Zorumski, CF1
Chen, C; Li, Q; Liu, YN; Xie, S; Xu, RA; Zhan, R1
Keidan, L; Pick, CG; Schreiber, S1
Blakely, RD; Groshan, K; Richelson, E; Tatsumi, M1

Reviews

79 review(s) available for fluoxetine and fluvoxamine

ArticleYear
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
    Current drug metabolism, 2005, Volume: 6, Issue:5

    Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic

2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.
    Journal of medicinal chemistry, 2020, 12-24, Volume: 63, Issue:24

    Topics: Allosteric Regulation; Clinical Trials as Topic; Humans; Ligands; Nervous System Diseases; Piperidines; Receptors, sigma; Sigma-1 Receptor; Small Molecule Libraries

2020
The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder.
    International clinical psychopharmacology, 1992, Volume: 7 Suppl 1

    Topics: Brain; Clomipramine; Dopamine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Serotonin; Tourette Syndrome

1992
Serotonergic probes in obsessive compulsive disorder.
    International clinical psychopharmacology, 1992, Volume: 7 Suppl 1

    Topics: Brain; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Receptors, Serotonin; Serotonin

1992
[New horizons in drug therapy of depression].
    Harefuah, 1992, Jun-01, Volume: 122, Issue:11

    Topics: Antidepressive Agents; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Time Factors

1992
Pharmacokinetics of the selective serotonin reuptake inhibitors.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline

1992
The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline

1992
Pharmacotherapy of obsessive compulsive disorder.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Piperidines; Serotonin; Sertraline

1992
The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy.
    Archives of general psychiatry, 1991, Volume: 48, Issue:11

    Topics: Antidepressive Agents; Depressive Disorder; Desipramine; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Imipramine; Mianserin; Suicide

1991
Obsessive-compulsive disorder.
    International clinical psychopharmacology, 1991, Volume: 6 Suppl 3

    Topics: Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder

1991
5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour.
    International clinical psychopharmacology, 1991, Volume: 6 Suppl 3

    Topics: Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Mianserin; Paroxetine; Piperidines; Serotonin Antagonists; Suicide; Suicide Prevention

1991
Fluoxetine and fluvoxamine.
    British journal of hospital medicine, 1991, Volume: 45, Issue:3

    Topics: Antidepressive Agents; Fluoxetine; Fluvoxamine; Humans; Oximes

1991
New pharmacologic approaches to obsessive compulsive disorder.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl

    Topics: Behavior Therapy; Clinical Trials as Topic; Clomipramine; Combined Modality Therapy; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Oximes

1990
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    The American journal of psychiatry, 1990, Volume: 147, Issue:9

    Topics: 1-Naphthylamine; Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Oximes; Placebos; Psychiatric Status Rating Scales; Serotonin; Serotonin Antagonists; Sertraline

1990
Biochemical pharmacology of the serotonin system.
    Advances in neurology, 1986, Volume: 43

    Topics: Alanine; Brain; Citalopram; Clomipramine; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Neurons; Oximes; p-Chloroamphetamine; Paroxetine; Piperidines; Propylamines; Receptors, Serotonin; Reserpine; Serotonin; Serotonin Antagonists; Synapses; Tetrabenazine; Zimeldine

1986
Therapeutic effects of serotonin uptake inhibitors in depression.
    The Journal of clinical psychiatry, 1986, Volume: 47 Suppl

    Topics: 5-Hydroxytryptophan; Alanine; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Imipramine; Oximes; Paroxetine; Piperidines; Propylamines; Serotonin; Serotonin Antagonists; Trazodone; Zimeldine

1986
Clinical experience with serotonin reuptake inhibiting antidepressants.
    The Journal of clinical psychiatry, 1987, Volume: 48 Suppl

    Topics: Citalopram; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Oximes; Propylamines; Serotonin Antagonists; Zimeldine

1987
Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.
    Journal of clinical psychopharmacology, 1987, Volume: 7, Issue:6 Suppl

    Topics: Animals; Antidepressive Agents; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Oximes; Serotonin; Serotonin Antagonists; Trazodone

1987
Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.
    International clinical psychopharmacology, 1995, Volume: 10 Suppl 1

    Topics: 1-Naphthylamine; Animals; Citalopram; Cytochrome P-450 Enzyme System; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereoisomerism

1995
Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
    The Annals of pharmacotherapy, 1994, Volume: 28, Issue:12

    Topics: 1-Naphthylamine; Alcoholism; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1994
Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.
    Archives of general psychiatry, 1995, Volume: 52, Issue:1

    Topics: 1-Naphthylamine; Adolescent; Adult; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1995
Management of treatment-refractory obsessive compulsive disorder patients.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl

    Topics: Antipsychotic Agents; Behavior Therapy; Clomipramine; Clonazepam; Combined Modality Therapy; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Treatment Outcome

1994
The pharmacogenetics of the selective serotonin reuptake inhibitors.
    The Clinical investigator, 1993, Volume: 71, Issue:12

    Topics: Antidepressive Agents; Citalopram; Cytochrome P-450 Enzyme System; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors

1993
The pharmacotherapy of obsessive-compulsive disorder.
    Pharmacopsychiatry, 1993, Volume: 26 Suppl 1

    Topics: 1-Naphthylamine; Buspirone; Clomipramine; Desipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

1993
[New antidepressive agents].
    L'union medicale du Canada, 1995, Volume: 124, Issue:3

    Topics: 1-Naphthylamine; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzamides; Child; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Moclobemide; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1995
Use of serotonin selective reuptake inhibitors in geriatric depression.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 5

    Topics: 1-Naphthylamine; Age Factors; Aged; Controlled Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1996
Are pharmacokinetic drug interactions with the SSRIs an issue?
    International clinical psychopharmacology, 1996, Volume: 11 Suppl 1

    Topics: Antidepressive Agents; Citalopram; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Liver; Selective Serotonin Reuptake Inhibitors

1996
Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1996, Sep-01, Volume: 155, Issue:5

    Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Female; Fluoxetine; Fluvoxamine; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Paroxetine; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part I.
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:4

    Topics: Cytochrome P-450 CYP1A1; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Isoenzymes; Microsomes, Liver; Paroxetine; Selective Serotonin Reuptake Inhibitors

1996
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
    Drug safety, 1996, Volume: 15, Issue:2

    Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan

1996
Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part II.
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:5

    Topics: 1-Naphthylamine; Animals; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Fluoxetine; Fluvoxamine; Humans; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Movement disorders associated with the serotonin selective reuptake inhibitors.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:10

    Topics: 1-Naphthylamine; Adult; Age Factors; Aged; Akathisia, Drug-Induced; Depressive Disorder; Dyskinesia, Drug-Induced; Dystonia; Female; Fluoxetine; Fluvoxamine; Humans; Male; MEDLINE; Middle Aged; Parkinson Disease, Secondary; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States

1996
The role of SSRIs in panic disorder.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 10

    Topics: 1-Naphthylamine; Citalopram; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1996
Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients.
    Journal of chromatography. B, Biomedical applications, 1996, Nov-08, Volume: 686, Issue:1

    Topics: 1-Naphthylamine; Chromatography; Citalopram; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:7

    Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride

1997
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
    Journal of sex & marital therapy, 1997,Fall, Volume: 23, Issue:3

    Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires

1997
Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs.
    Mayo Clinic proceedings, 1997, Volume: 72, Issue:9

    Topics: 1-Naphthylamine; Antidepressive Agents; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride

1997
Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 12

    Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1997
The use of newer antidepressants for panic disorder.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 14

    Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride

1997
Pharmacokinetic interactions of antidepressants.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 10

    Topics: Antidepressive Agents; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Mixed Function Oxygenases; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride

1998
SSRI safety in overdose.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 15

    Topics: Adult; Child; Citalopram; Drug Overdose; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Poison Control Centers; Selective Serotonin Reuptake Inhibitors; Sertraline; United States

1998
Depression and dementia: comorbidities, identification, and treatment.
    Journal of geriatric psychiatry and neurology, 1998,Winter, Volume: 11, Issue:4

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
Current concepts in the treatment of panic disorder.
    The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 18

    Topics: Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1999
Pharmacokinetics of selective serotonin reuptake inhibitors.
    Pharmacology & therapeutics, 2000, Volume: 85, Issue:1

    Topics: Citalopram; Clinical Trials as Topic; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

2000
On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2000, Volume: 45, Issue:3

    Topics: Clomipramine; Double-Blind Method; Expert Testimony; Fluoxetine; Fluvoxamine; Guidelines as Topic; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2000
Pharmacoeconomic studies of antidepressants: focus on venlafaxine.
    Depression and anxiety, 2000, Volume: 12 Suppl 1

    Topics: Antidepressive Agents, Second-Generation; Buspirone; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Drug Tolerance; Fluoxetine; Fluvoxamine; Humans; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride

2000
Psychopharmacologic treatment of adolescent depression.
    Archives of psychiatric nursing, 2001, Volume: 15, Issue:1

    Topics: Adolescent; Child; Cyclohexanols; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride

2001
The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.
    The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 20

    Topics: Alcohol Drinking; Alcoholism; Animals; Behavior, Addictive; Behavior, Animal; Citalopram; Clinical Trials as Topic; Comorbidity; Drinking Behavior; Drug Evaluation, Preclinical; Fluoxetine; Fluvoxamine; Humans; Mice; Rats; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2001
Serotonin agents in the treatment of acquired brain injury.
    The Journal of head trauma rehabilitation, 2002, Volume: 17, Issue:4

    Topics: Brain Injuries; Citalopram; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Injury Severity Score; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2002
Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.
    Biological psychiatry, 2002, Dec-15, Volume: 52, Issue:12

    Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride

2002
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania

2003
Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
    The Annals of pharmacotherapy, 2004, Volume: 38, Issue:9

    Topics: Autistic Disorder; Citalopram; Clinical Trials as Topic; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline

2004
Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:10

    Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Chemotherapy, Adjuvant; Fluoxetine; Fluvoxamine; Humans; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors

2004
Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders.
    Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:5

    Topics: Adolescent; Antipsychotic Agents; Child; Child Behavior Disorders; Child Development Disorders, Pervasive; Cross-Over Studies; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Randomized Controlled Trials as Topic; Reproducibility of Results; Risperidone; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome

2005
Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.
    International journal of clinical practice, 2005, Volume: 59, Issue:12

    Topics: Antidepressive Agents, Second-Generation; Citalopram; Fluoxetine; Fluvoxamine; Humans; Mood Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

2005
[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:10 Pt 2

    Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Second-Generation; Case-Control Studies; Child, Preschool; Citalopram; Confidence Intervals; Depressive Disorder; Family Practice; Female; Fluoxetine; Fluvoxamine; History, Medieval; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Psychotherapy; Randomized Controlled Trials as Topic; Risk; Safety; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Suicide; Suicide, Attempted

2006
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
    Biological psychiatry, 2008, Feb-15, Volume: 63, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride

2008
Use of medication in children with psychiatric disorders.
    Community practitioner : the journal of the Community Practitioners' & Health Visitors' Association, 2007, Volume: 80, Issue:11

    Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; Drug Prescriptions; Drug Utilization; Fluoxetine; Fluvoxamine; Health Policy; Humans; Melatonin; Mental Disorders; Methylphenidate; Needs Assessment; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Propylamines; Psychotropic Drugs; Risperidone; Sertraline; United Kingdom

2007
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
    Obstetrics and gynecology, 2008, Volume: 111, Issue:5

    Topics: Adult; Citalopram; Female; Fluoxetine; Fluvoxamine; Humans; Odds Ratio; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2008
Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:2 Pt 2

    Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2010
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    International clinical psychopharmacology, 2010, Volume: 25, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult

2010
Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
    Expert review of neurotherapeutics, 2010, Volume: 10, Issue:8

    Topics: Citalopram; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Placebo Effect; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2010
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
    Postgraduate medicine, 2010, Volume: 122, Issue:4

    Topics: Abnormalities, Drug-Induced; Cardiovascular Abnormalities; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Maternal-Fetal Exchange; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Teratogens

2010
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
    The Cochrane database of systematic reviews, 2010, Aug-04, Issue:8

    Topics: Adult; Age Factors; Autistic Disorder; Child; Citalopram; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors

2010
[Selective serotonin reuptake inhibitors and mammary pathologies].
    Voprosy onkologii, 2010, Volume: 56, Issue:4

    Topics: Antidepressive Agents; Breast Neoplasms; Citalopram; Clinical Trials as Topic; Female; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline

2010
Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
    Current medicinal chemistry, 2012, Volume: 19, Issue:12

    Topics: Benzofurans; Citalopram; Depressive Disorder; Drug Monitoring; Fluoxetine; Fluvoxamine; Humans; Indoles; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Vilazodone Hydrochloride

2012
Drug interactions in the treatment of depression in patients with ischemic heart disease.
    The Journal of clinical psychiatry, 2012, Volume: 73, Issue:12

    Topics: Aged; Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Comorbidity; Cytochrome P-450 CYP2C19; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Early Diagnosis; Fluoxetine; Fluvoxamine; Gastrointestinal Hemorrhage; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Selective Serotonin Reuptake Inhibitors; Ticlopidine

2012
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
    The Cochrane database of systematic reviews, 2013, Aug-20, Issue:8

    Topics: Adult; Age Factors; Autistic Disorder; Child; Child Development Disorders, Pervasive; Citalopram; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors

2013
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    The Cochrane database of systematic reviews, 2015, 05-01, Issue:5

    Topics: Adrenergic Uptake Inhibitors; Adult; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Norepinephrine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Tension-Type Headache; Venlafaxine Hydrochloride

2015
Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.
    The American journal of psychiatry, 2016, Feb-01, Volume: 173, Issue:2

    Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2016
Antidepressant pharmacogenetics in children and young adults: A systematic review.
    Journal of affective disorders, 2019, 07-01, Volume: 254

    Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mental Disorders; Nortriptyline; Paroxetine; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult

2019
Exploring the utility of RDoC in differentiating effectiveness amongst antidepressants: A systematic review using proposed psychometrics as the unit of analysis for the Negative Valence Systems domain.
    PloS one, 2020, Volume: 15, Issue:12

    Topics: Algorithms; Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depressive Disorder; Desvenlafaxine Succinate; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Psychometrics; Sertraline; Treatment Outcome

2020
Recent sample pretreatment methods for determination of selective serotonin reuptake inhibitors (SSRIs) in biological samples.
    Journal of pharmaceutical and biomedical analysis, 2021, Nov-30, Volume: 206

    Topics: Citalopram; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors

2021
Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19.
    International journal of molecular sciences, 2022, Mar-30, Volume: 23, Issue:7

    Topics: Antidepressive Agents; COVID-19 Drug Treatment; Fluoxetine; Fluvoxamine; Humans; Pandemics; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors

2022
Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use.
    European journal of clinical pharmacology, 2022, Volume: 78, Issue:10

    Topics: Antidepressive Agents; Antiviral Agents; COVID-19 Drug Treatment; Fluoxetine; Fluvoxamine; Humans; Receptors, Serotonin; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors; Serotonin

2022
The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis.
    PloS one, 2022, Volume: 17, Issue:10

    Topics: Antidepressive Agents; COVID-19 Drug Treatment; Fluoxetine; Fluvoxamine; Humans; Norepinephrine; Paroxetine; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride

2022
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
    Molecular psychiatry, 2023, Volume: 28, Issue:1

    Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine

2023
Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023, Volume: 29, Issue:5

    Topics: COVID-19; Fluoxetine; Fluvoxamine; Humans; Selective Serotonin Reuptake Inhibitors

2023

Trials

38 trial(s) available for fluoxetine and fluvoxamine

ArticleYear
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    The American journal of psychiatry, 1990, Volume: 147, Issue:9

    Topics: 1-Naphthylamine; Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Oximes; Placebos; Psychiatric Status Rating Scales; Serotonin; Serotonin Antagonists; Sertraline

1990
Clinical experience with serotonin reuptake inhibiting antidepressants.
    The Journal of clinical psychiatry, 1987, Volume: 48 Suppl

    Topics: Citalopram; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Oximes; Propylamines; Serotonin Antagonists; Zimeldine

1987
Are SSRI antidepressants a clinically homogeneous class of compounds?
    Lancet (London, England), 1994, Jul-09, Volume: 344, Issue:8915

    Topics: Adult; Aged; Bipolar Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors

1994
Carbamazepine coadministration with fluoxetine or fluvoxamine.
    Therapeutic drug monitoring, 1993, Volume: 15, Issue:3

    Topics: Adult; Carbamazepine; Depression; Drug Interactions; Drug Therapy, Combination; Epilepsy, Complex Partial; Epilepsy, Tonic-Clonic; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged

1993
An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression.
    The Journal of clinical psychiatry, 1993, Volume: 54, Issue:7

    Topics: Adult; Ambulatory Care; Buspirone; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors

1993
Response to an open trial of a second SSRI in major depression.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:3

    Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1996
Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients.
    Pharmacological research, 1995, Volume: 31, Issue:6

    Topics: Adult; Amitriptyline; Antipsychotic Agents; Clomipramine; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Pharmacogenetics; Phenotype

1995
Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.
    European journal of clinical pharmacology, 1996, Volume: 51, Issue:1

    Topics: Adult; Aryl Hydrocarbon Hydroxylases; Caffeine; Chromatography, High Pressure Liquid; Citalopram; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Male; Mephenytoin; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sparteine

1996
A comparison of fluvoxamine and fluoxetine in the treatment of major depression.
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:5

    Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors

1996
Serotonergic drugs in trichotillomania: treatment results in 12 patients.
    The Journal of nervous and mental disease, 1996, Volume: 184, Issue:10

    Topics: Adolescent; Adult; Age of Onset; Clomipramine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Trichotillomania

1996
Drug treatment of obsessive-compulsive disorder (OCD): long-term trial with clomipramine and selective serotonin reuptake inhibitors (SSRIs).
    Psychopharmacology bulletin, 1996, Volume: 32, Issue:1

    Topics: Adult; Clomipramine; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Time Factors

1996
Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer.
    Alcoholism, clinical and experimental research, 1996, Volume: 20, Issue:8

    Topics: Alcoholism; Anti-Anxiety Agents; Buspirone; Dose-Response Relationship, Drug; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Patient Compliance; Riboflavin; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Ultraviolet Rays

1996
Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:1

    Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Selective Serotonin Reuptake Inhibitors

1997
19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder.
    The American journal of psychiatry, 1997, Volume: 154, Issue:4

    Topics: Adolescent; Adult; Aged; Brain; Brain Chemistry; Drug Administration Schedule; Fluorine; Fluoxetine; Fluvoxamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Obsessive-Compulsive Disorder; Tissue Distribution; Treatment Outcome

1997
Personality disorder scores improve with effective pharmacotherapy of depression.
    Journal of affective disorders, 1997, Volume: 43, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Ergolines; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Disorders; Personality Inventory; Serotonin Antagonists

1997
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    The American journal of psychiatry, 1997, Volume: 154, Issue:9

    Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Adult; Clomipramine; Desipramine; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1997
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
    Journal of sex & marital therapy, 1997,Fall, Volume: 23, Issue:3

    Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires

1997
Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
    Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:4

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Double-Blind Method; Ejaculation; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Reaction Time; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
Cardiac side-effects of two selective serotonin reuptake inhibitors in middle-aged and elderly depressed patients.
    International clinical psychopharmacology, 1998, Volume: 13, Issue:6

    Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Depressive Disorder; Double-Blind Method; Echocardiography; Electrocardiography; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors

1998
Prolactin response to d-fenfluramine in major depression before and after treatment with serotonin reuptake inhibitors.
    Biological psychiatry, 1999, Feb-01, Volume: 45, Issue:3

    Topics: Adult; Analysis of Variance; Depressive Disorder; Double-Blind Method; Female; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Male; Prolactin; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Time Factors

1999
A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Archives of general psychiatry, 1999, Volume: 56, Issue:4

    Topics: Adult; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Pindolol; Placebos; Selective Serotonin Reuptake Inhibitors; Single-Blind Method

1999
CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline.
    Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:2

    Topics: Adult; Cytochrome P-450 CYP2D6; Dextromethorphan; Dextrorphan; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Reference Values; Sertraline

1999
Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three cases.
    Journal of child and adolescent psychopharmacology, 1999, Volume: 9, Issue:1

    Topics: Adult; Chronic Disease; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Trichotillomania

1999
Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
    The Journal of clinical psychiatry, 1999, Volume: 60, Issue:9

    Topics: Ambulatory Care; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Administration Schedule; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Implosive Therapy; Obsessive-Compulsive Disorder; Pilot Projects; Psychiatric Status Rating Scales; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

1999
Derivation of the SPAN, a brief diagnostic screening test for post-traumatic stress disorder.
    Psychiatry research, 1999, Oct-18, Volume: 88, Issue:1

    Topics: Adult; Antidepressive Agents; Cohort Studies; Combat Disorders; Disasters; Female; Fluoxetine; Fluvoxamine; Humans; Lamotrigine; Male; Middle Aged; Personality Inventory; Piperazines; Psychometrics; Rape; Reproducibility of Results; Stress Disorders, Post-Traumatic; Triazines; Triazoles

1999
On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2000, Volume: 45, Issue:3

    Topics: Clomipramine; Double-Blind Method; Expert Testimony; Fluoxetine; Fluvoxamine; Guidelines as Topic; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2000
Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:2

    Topics: Fluoxetine; Fluvoxamine; Humans; Methadone; Narcotics; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric; Stereoisomerism; Substance-Related Disorders

1997
Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2000, Volume: 10, Issue:5

    Topics: Adult; Antidepressive Agents; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires; Time Factors

2000
An open trial of light therapy for women with seasonal affective disorder and comorbid bulimia nervosa.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:3

    Topics: Adolescent; Adult; Bulimia; Comorbidity; Female; Fluoxetine; Fluvoxamine; Humans; Multi-Institutional Systems; Personality Inventory; Phototherapy; Placebos; Psychiatric Status Rating Scales; Retrospective Studies; Seasonal Affective Disorder; Severity of Illness Index; Treatment Outcome

2001
Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:7

    Topics: Adolescent; Adult; Age of Onset; Ambulatory Care; Behavior Therapy; Clomipramine; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Probability; Prognosis; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2001
CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6.
    Pharmacotherapy, 2002, Volume: 22, Issue:8

    Topics: Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Dextrorphan; Fluoxetine; Fluvoxamine; Genotype; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

2002
Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study.
    Journal of child and adolescent psychopharmacology, 2002,Fall, Volume: 12, Issue:3

    Topics: Adolescent; Anxiety Disorders; Child; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Pediatrics; Psychopharmacology; Regression Analysis

2002
Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison.
    Human psychopharmacology, 2003, Volume: 18, Issue:5

    Topics: Adolescent; Adult; Aged; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors

2003
Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone.
    Journal of clinical pharmacology, 2003, Volume: 43, Issue:11

    Topics: Administration, Oral; Adult; Analysis of Variance; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Humans; Ketoconazole; Male; Midazolam; Piperazines; Triazoles

2003
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:10

    Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obesity; Obsessive-Compulsive Disorder; Paroxetine; Patient Compliance; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain

2004
Phenytoin as an augmentation for SSRI failures: a small controlled study.
    Journal of affective disorders, 2006, Volume: 96, Issue:1-2

    Topics: Adult; Aged; Anticonvulsants; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Phenytoin; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2006
Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules.
    International journal of cardiology, 2010, Mar-04, Volume: 139, Issue:2

    Topics: Adult; Aged; Aorta; Cell Adhesion; Cell Survival; Chronic Disease; Citalopram; Depression; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Fluoxetine; Fluvoxamine; Heart Failure; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Monocytes; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Tumor Necrosis Factor-alpha; U937 Cells; Vascular Cell Adhesion Molecule-1

2010
[Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2021, Volume: 121, Issue:12

    Topics: Alcoholism; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

2021

Other Studies

182 other study(ies) available for fluoxetine and fluvoxamine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:3

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations

2002
Inhibition of P-glycoprotein by newer antidepressants.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:1

    Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Endothelium, Vascular; Humans; Reproducibility of Results; Swine; Transfection

2003
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
    Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19

    Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2

    Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution

2011
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:5

    Topics: Amiodarone; Astemizole; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Danazol; Drug Discovery; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Methylation; Microsomes, Liver; Models, Biological; Molecular Structure; Substrate Specificity; Tandem Mass Spectrometry; Terfenadine

2012
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
    Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10

    Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers

2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands - Fluoxetine and fluvoxamine.
    European journal of medicinal chemistry, 2021, Aug-05, Volume: 220

    Topics: Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Ligands; Models, Molecular; Molecular Structure; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship

2021
Effects of inhibitors of neuronal uptake of 5-HT on sympathetic cardiovascular regulation.
    Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:1

    Topics: Analysis of Variance; Animals; Blood Platelets; Blood Pressure; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Heart Rate; Norepinephrine; Rabbits; Serotonin; Sympathetic Nervous System

1992
Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias.
    The Journal of clinical psychiatry, 1992, Volume: 53, Issue:8

    Topics: Adolescent; Adult; Behavior, Addictive; Clomipramine; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paraphilic Disorders; Psychiatric Status Rating Scales; Retrospective Studies; Serotonin

1992
The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
    British journal of clinical pharmacology, 1992, Volume: 34, Issue:3

    Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sparteine

1992
Treatment outcome of obsessive compulsive disorder with comorbid social phobia.
    The Journal of clinical psychiatry, 1992, Volume: 53, Issue:11

    Topics: Adult; Clomipramine; Comorbidity; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Phenelzine; Phobic Disorders; Probability; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

1992
Metabolic interaction between tricyclic antidepressant and fluvoxamine and fluoxetine, a pharmacogenetic approach.
    Clinical neuropharmacology, 1992, Volume: 15 Suppl 1 Pt A

    Topics: Adult; Antidepressive Agents, Tricyclic; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Pharmacogenetics

1992
Pharmacokinetics of fluoxetine and fluvoxamine in depressed patients: personal results.
    Clinical neuropharmacology, 1992, Volume: 15 Suppl 1 Pt A

    Topics: Biotransformation; Chromatography, High Pressure Liquid; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans

1992
Sodium valproate augmentation of fluoxetine or fluvoxamine effects.
    Biological psychiatry, 1992, Jun-01, Volume: 31, Issue:11

    Topics: Aged; Aged, 80 and over; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Valproic Acid

1992
Fluoxetine and fluvoxamine in PTSD.
    The American journal of psychiatry, 1992, Volume: 149, Issue:3

    Topics: Adult; Drug Evaluation; Fluoxetine; Fluvoxamine; Humans; Male; Serotonin; Stress Disorders, Post-Traumatic; Veterans

1992
Extremely long plasma half-life of amitriptyline in a woman with the cytochrome P450IID6 29/29-kilobase wild-type allele--a slowly reversible interaction with fluoxetine.
    Therapeutic drug monitoring, 1991, Volume: 13, Issue:6

    Topics: Alleles; Amitriptyline; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Debrisoquin; Depression; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Half-Life; Humans; Middle Aged; Nortriptyline; Phenotype; Spectrophotometry, Ultraviolet

1991
Fluoxetine, fluvoxamine and extrapyramidal tract disorders.
    International clinical psychopharmacology, 1991,Spring, Volume: 6, Issue:1

    Topics: Adult; Basal Ganglia Diseases; Female; Fluoxetine; Fluvoxamine; Humans; Mental Disorders; Middle Aged; Movement; Oximes; Serotonin Antagonists

1991
Are effective antiobsessional drugs interchangeable?
    Archives of general psychiatry, 1991, Volume: 48, Issue:9

    Topics: Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Research Design; Serotonin Antagonists

1991
Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment.
    The Journal of clinical psychiatry, 1990, Volume: 51, Issue:3

    Topics: Adult; Clomipramine; Drug Administration Schedule; Drug Therapy, Combination; Female; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Oximes; Serotonin Antagonists

1990
Treatment of depersonalization with serotonin reuptake blockers.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:3

    Topics: Adolescent; Adult; Clomipramine; Depersonalization; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Oximes; Panic; Serotonin Antagonists

1990
Apathy and indifference in patients on fluvoxamine and fluoxetine.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:5

    Topics: Adult; Agoraphobia; Antidepressive Agents; Anxiety Disorders; Arousal; Depressive Disorder; Dose-Response Relationship, Drug; Fatigue; Female; Fluoxetine; Fluvoxamine; Humans; Impulsive Behavior; Male; Middle Aged; Motivation; Oximes; Panic; Serotonin Antagonists

1990
Obsessive-compulsive disorder.
    American family physician, 1989, Volume: 39, Issue:5

    Topics: Adult; Behavior Therapy; Clomipramine; Diagnosis, Differential; Female; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Oximes; Physicians, Family; Serotonin Antagonists

1989
Obsessive compulsive disorder.
    The Journal of clinical psychiatry, 1989, Volume: 50, Issue:6

    Topics: Behavior Therapy; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Oximes

1989
5-HT reuptake inhibitors in healthy human subjects.
    Clinical neuropharmacology, 1986, Volume: 9 Suppl 4

    Topics: Fluoxetine; Fluvoxamine; Humans; Neuropsychological Tests; Oximes; Propylamines; Psychometrics; Serotonin; Serotonin Antagonists

1986
Interactions of 5HT reuptake inhibitors and ethanol in tests of exploration and anxiety.
    Advances in alcohol & substance abuse, 1988, Volume: 7, Issue:3-4

    Topics: Animals; Anxiety; Citalopram; Desipramine; Drug Interactions; Ethanol; Exploratory Behavior; Fluoxetine; Fluvoxamine; Mice; Mice, Inbred Strains; Motor Activity; Oximes; Serotonin Antagonists

1988
Behavioral interactions of fluoxetine and other 5-hydroxytryptamine uptake inhibitors with ethanol in tests of anxiety, locomotion and exploration.
    Psychopharmacology, 1988, Volume: 96, Issue:4

    Topics: Animals; Anxiety; Citalopram; Desipramine; Ethanol; Exploratory Behavior; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Oximes; Serotonin Antagonists

1988
The antidepressant agents desipramine, fluoxetine, fluvoxamine and norzimelidine inhibit uptake of [3H]noradrenaline and [3H]5-hydroxytryptamine in slices of human and rat cortical brain tissue.
    Brain research, 1983, Sep-19, Volume: 275, Issue:1

    Topics: Absorption; Animals; Antidepressive Agents; Cerebral Cortex; Desipramine; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Male; Norepinephrine; Oximes; Rats; Serotonin; Zimeldine

1983
Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors.
    Biochemical pharmacology, 1983, Apr-01, Volume: 32, Issue:7

    Topics: Animals; Antidepressive Agents, Tricyclic; Brain; Brompheniramine; Cattle; Fluoxetine; Fluvoxamine; Male; Neurons; Oximes; Propylamines; Rats; Rats, Inbred Strains; Receptors, Histamine; Receptors, Neurotransmitter; Serotonin; Zimeldine

1983
Effects of chronic treatment with antidepressants on aggressiveness induced by clonidine in mice.
    Journal of neural transmission, 1982, Volume: 55, Issue:1

    Topics: Aggression; Animals; Antidepressive Agents; Citalopram; Clonidine; Drug Interactions; Fluoxetine; Flupenthixol; Fluvoxamine; Humans; Male; Mice; Oximes; Pizotyline; Propylamines; Stereoisomerism

1982
The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
    British journal of pharmacology, 1993, Volume: 110, Issue:1

    Topics: 1-Naphthylamine; Animals; Appetite Depressants; Brain Chemistry; Eating; Fluoxetine; Fluvoxamine; Hydroxyindoleacetic Acid; Indoles; Male; Paroxetine; Rats; Rats, Inbred Strains; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline

1993
Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
    European journal of pharmacology, 1994, Nov-03, Volume: 264, Issue:3

    Topics: 1-Naphthylamine; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Analysis of Variance; Animals; Behavior, Animal; Brain; Citalopram; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Fluvoxamine; Male; Mice; Paroxetine; Penbutolol; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Sertraline; Synaptosomes

1994
In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine.
    Synapse (New York, N.Y.), 1994, Volume: 18, Issue:4

    Topics: Animals; Antidepressive Agents; Biogenic Monoamines; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Fluoxetine; Fluvoxamine; Imipramine; Male; Microdialysis; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Serotonin

1994
Are SSRI antidepressants clinically homogeneous?
    Lancet (London, England), 1994, Aug-20, Volume: 344, Issue:8921

    Topics: Depressive Disorder; Fluoxetine; Fluvoxamine; Humans

1994
Chlorimipramine and nortriptyline but not fluoxetine and fluvoxamine inhibit human polymorphonuclear cell chemotaxis in vitro.
    General pharmacology, 1994, Volume: 25, Issue:3

    Topics: Antidepressive Agents; Chemotaxis, Leukocyte; Clomipramine; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Neutrophils; Nortriptyline

1994
Prescription-event monitoring of 10,401 patients treated with fluvoxamine.
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 164, Issue:3

    Topics: Adolescent; Adult; Aged; Anxiety Disorders; Depressive Disorder; Drug Monitoring; Drug Prescriptions; Drug Therapy, Combination; England; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Pregnancy; Product Surveillance, Postmarketing; Sex Factors

1994
Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine.
    The American journal of psychiatry, 1994, Volume: 151, Issue:10

    Topics: Adult; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Severity of Illness Index

1994
Pharmacologic management of obsessive-compulsive disorder.
    Southern medical journal, 1994, Volume: 87, Issue:3

    Topics: 1-Naphthylamine; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depression; Dopamine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Trazodone

1994
Emergence of depressive symptoms during treatment for panic disorder with specific 5-hydroxytryptophan reuptake inhibitors.
    Acta psychiatrica Scandinavica, 1993, Volume: 88, Issue:4

    Topics: Adult; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Panic Disorder; Suicide

1993
Antisocial ideation and activities precipitated by the administration of SSRIs.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1993, Volume: 38, Issue:10

    Topics: Adult; Antisocial Personality Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Impulsive Behavior; Male; Risk Factors; Selective Serotonin Reuptake Inhibitors

1993
Drug-induced mania.
    Hospital & community psychiatry, 1993, Volume: 44, Issue:7

    Topics: Bipolar Disorder; Clomipramine; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Risk Factors

1993
Differential effects of fluoxetine on isoprenaline-stimulated water intake in ethanol-treated rats: a role for beta-adrenoceptors.
    European journal of pharmacology, 1993, Jun-24, Volume: 237, Issue:2-3

    Topics: Analysis of Variance; Animals; Desipramine; Drinking; Drug Interactions; Ethanol; Fluoxetine; Fluvoxamine; Injections, Intraperitoneal; Isoproterenol; Male; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Zimeldine

1993
[Risk of hemorrhage with the use of fluoxetine (Prozac) or fluvoxamine (Fevarin)].
    Nederlands tijdschrift voor geneeskunde, 1993, Jan-30, Volume: 137, Issue:5

    Topics: Adult; Female; Fluoxetine; Fluvoxamine; Hematoma; Hemorrhage; Humans

1993
Blood-letting in bulimia nervosa.
    The British journal of psychiatry : the journal of mental science, 1993, Volume: 162

    Topics: Adult; Bloodletting; Bulimia; Child of Impaired Parents; Combined Modality Therapy; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Personality Development; Phenelzine; Phototherapy; Psychotherapy; Psychotherapy, Group; Students, Medical

1993
[Risk of hemorrhage with administration of fluoxetine (Prozac) or fluvoxamine (Fevarin)].
    Nederlands tijdschrift voor geneeskunde, 1993, Mar-20, Volume: 137, Issue:12

    Topics: Ascorbic Acid; Ecchymosis; Female; Fluoxetine; Fluvoxamine; Humans

1993
Pharmacological properties of 403U76, a new chemical class of 5-hydroxytryptamine- and noradrenaline-reuptake inhibitor.
    The Journal of pharmacy and pharmacology, 1995, Volume: 47, Issue:9

    Topics: 5-Hydroxytryptophan; Adrenergic Uptake Inhibitors; Animals; Animals, Newborn; Benzyl Alcohols; Binding, Competitive; Dogs; Electrophysiology; Fluoxetine; Fluvoxamine; Hemodynamics; Imipramine; Male; Mice; Neurons; Norepinephrine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Species Specificity; Synaptic Transmission; Tetrabenazine; Vocalization, Animal

1995
Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors.
    Clinical neuropharmacology, 1995, Volume: 18, Issue:4

    Topics: Adult; Clomipramine; Cyproheptadine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological

1995
In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 278, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Animals; Carrier Proteins; Cerebral Cortex; Citalopram; Clonidine; Desipramine; Fluoxetine; Fluvoxamine; Imipramine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Raphe Nuclei; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters

1996
Simultaneous determination of plasma levels of fluvoxamine and of the enantiomers of fluoxetine and norfluoxetine by gas chromatography-mass spectrometry.
    Journal of chromatography. B, Biomedical applications, 1996, Jul-12, Volume: 682, Issue:2

    Topics: Fluoxetine; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism

1996
Fluoxetine addition to methadone in addicts: pharmacokinetic aspects.
    Therapeutic drug monitoring, 1996, Volume: 18, Issue:5

    Topics: Adult; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Humans; Male; Methadone; Mood Disorders; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders

1996
Predicting value of tryptophan/large neutral amino acids ratio on selective serotonin reuptake inhibitors.
    Advances in experimental medicine and biology, 1996, Volume: 398

    Topics: Amino Acids; Antidepressive Agents; Biomarkers; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Tryptophan

1996
Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects.
    International clinical psychopharmacology, 1996, Volume: 11, Issue:3

    Topics: 1-Naphthylamine; Aged; Anorexia; Antidepressive Agents; Depressive Disorder; Diarrhea; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Nausea; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method

1996
[Reports of suspected side effects of selective serotonin reuptake inhibitors in Belgium and The Netherlands].
    Nederlands tijdschrift voor geneeskunde, 1996, Sep-07, Volume: 140, Issue:36

    Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Belgium; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Netherlands; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Effects of antidepressants on the cytochrome P450 system.
    The American journal of psychiatry, 1996, Volume: 153, Issue:12

    Topics: 1-Naphthylamine; Antidepressive Agents; Cytochrome P-450 Enzyme System; Fluoxetine; Fluvoxamine; Humans; Medical Records; Paroxetine; Research Design; Sertraline

1996
A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
    British journal of clinical pharmacology, 1996, Volume: 42, Issue:6

    Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome

1996
A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: a retrospective study.
    The Bulletin of the American Academy of Psychiatry and the Law, 1996, Volume: 24, Issue:4

    Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Fluoxetine; Fluvoxamine; Humans; Libido; Male; Middle Aged; Paraphilic Disorders; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1996
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
    Psychopharmacology, 1997, Volume: 129, Issue:3

    Topics: 1-Naphthylamine; Aggression; Animals; Anxiety; Binding, Competitive; Citalopram; Depression; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sertraline; Vocalization, Animal

1997
Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat.
    Journal of psychopharmacology (Oxford, England), 1997, Volume: 11, Issue:1

    Topics: 1-Naphthylamine; Animals; Behavior, Animal; Chlorpromazine; Citalopram; Fluoxetine; Fluvoxamine; Guanidines; Haloperidol; Male; Microinjections; Motor Activity; Paroxetine; Piperidines; Posture; Rats; Rats, Sprague-Dawley; Receptors, sigma; Red Nucleus; Selective Serotonin Reuptake Inhibitors; Sertraline

1997
Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitors.
    Clinical neuropharmacology, 1997, Volume: 20, Issue:2

    Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Disruptive, Impulse Control, and Conduct Disorders; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors

1997
Effects of fluoxetine hydrochloride and fluvoxamine maleate on different preparations of isolated guinea pig and rat organ tissues.
    General pharmacology, 1997, Volume: 28, Issue:4

    Topics: Acetylcholine; Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Guinea Pigs; In Vitro Techniques; Male; Muscle, Smooth; Norepinephrine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Histamine; Receptors, Muscarinic; Selective Serotonin Reuptake Inhibitors

1997
Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.
    European journal of pharmacology, 1997, May-01, Volume: 325, Issue:2-3

    Topics: Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Desipramine; Drug Interactions; Fluoxetine; Fluvoxamine; Imipramine; Ketanserin; Male; Maprotiline; Mice; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming

1997
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:4

    Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Anxiety Disorders; Bupropion; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Epilepsy; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1997
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
    British journal of clinical pharmacology, 1997, Volume: 43, Issue:6

    Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Fluoxetine; Fluvoxamine; Frozen Sections; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Lethal Dose 50; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Venlafaxine Hydrochloride

1997
[A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1997, Volume: 97, Issue:4

    Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Evaluation; Female; Fluoxetine; Fluvoxamine; Humans; Male; Maprotiline; Middle Aged; Time Factors

1997
ACTH 4-9 analogue facilitates the antiimmobility effect of antidepressants and dopamine agonists in swimming rats.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 1997, Volume: 48, Issue:2

    Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Dopamine Agonists; Exploratory Behavior; Fear; Fluoxetine; Fluvoxamine; Monoamine Oxidase Inhibitors; Motor Activity; Peptide Fragments; Piribedil; Quinpirole; Rats; Rats, Wistar; Selegiline; Swimming

1997
Psychopharmacology of comorbid obsessive-compulsive disorder and depression.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 8

    Topics: Comorbidity; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors

1997
Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine.
    Proceedings of the National Academy of Sciences of the United States of America, 1998, Mar-17, Volume: 95, Issue:6

    Topics: Adult; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Pregnanolone; Psychometrics; Selective Serotonin Reuptake Inhibitors; Stereoisomerism

1998
Pinch-induced catalepsy in mice: a useful model to investigate antidepressant or anxiolytic drugs.
    Progress in neuro-psychopharmacology & biological psychiatry, 1998, Volume: 22, Issue:1

    Topics: Amitriptyline; Animals; Anti-Anxiety Agents; Antidepressive Agents; Catalepsy; Female; Fluoxetine; Fluvoxamine; Imipramine; Learning; Male; Mice; Models, Psychological; Motor Activity; Ondansetron; Physical Stimulation; Reaction Time; Serotonin Antagonists; Sex Characteristics; Stereotyped Behavior

1998
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
    Fundamental & clinical pharmacology, 1998, Volume: 12, Issue:2

    Topics: Buprenorphine; Cytochrome P-450 Enzyme System; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Linear Models; Methadone; Microsomes, Liver; Narcotic Antagonists; Narcotics; Selective Serotonin Reuptake Inhibitors

1998
[Choice of therapeutic tactics in treatment of endogenous depression by means of statusmetric expert system].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1997, Volume: 97, Issue:12

    Topics: 1-Naphthylamine; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome

1997
Selective serotonin reuptake inhibitors may enhance responses to noxious stimulation.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:3

    Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Fluvoxamine; Heart Rate; Hot Temperature; Male; Pain; Pain Measurement; Rats; Rats, Wistar; Reaction Time; Selective Serotonin Reuptake Inhibitors

1998
The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors.
    European journal of clinical pharmacology, 1998, Volume: 54, Issue:3

    Topics: 1-Naphthylamine; Adult; Anti-Arrhythmia Agents; Child; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Kinetics; Male; Methylation; Metoprolol; Microsomes, Liver; Oxidation-Reduction; Paroxetine; Quinidine; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
    Psychopharmacology, 1998, Volume: 138, Issue:2

    Topics: Animals; Antidepressive Agents; Buspirone; Citalopram; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exercise Test; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming

1998
Stimulus properties of fluvoxamine in a conditioned taste aversion procedure.
    Psychopharmacology, 1998, Volume: 140, Issue:4

    Topics: Animals; Avoidance Learning; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Taste

1998
Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:12

    Topics: Adolescent; Adult; Child; Citalopram; Cytochrome P-450 Enzyme System; Drug Prescriptions; Fluoxetine; Fluvoxamine; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
Divided attention in major depression.
    Psychiatry research, 1998, Dec-14, Volume: 81, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Attention; Decision Making; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Middle Aged; Reaction Time

1998
Milnacipran: new preparation. Tricyclics remain first-line antidepressants.
    Prescrire international, 1998, Volume: 7, Issue:34

    Topics: Amitriptyline; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclopropanes; Drug Evaluation; Europe; Fluoxetine; Fluvoxamine; Humans; Imipramine; Meta-Analysis as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; United States

1998
Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats.
    Alcohol (Fayetteville, N.Y.), 1999, Volume: 17, Issue:3

    Topics: Alcohol Drinking; Alcoholism; Animals; Citalopram; Disease Models, Animal; Eating; Ethanol; Female; Fluoxetine; Fluvoxamine; Food Preferences; Male; Paroxetine; Rats; Rats, Mutant Strains; Selective Serotonin Reuptake Inhibitors

1999
Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress.
    European journal of pharmacology, 1999, Apr-29, Volume: 371, Issue:2-3

    Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Dendritic Cells; Fluoxetine; Fluvoxamine; Golgi Apparatus; Hippocampus; Male; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, Serotonin; Restraint, Physical; Stress, Physiological; Thiazepines

1999
The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of thioridazine and its metabolites: in vivo and in vitro studies.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 1999, Volume: 51, Issue:4-5

    Topics: Animals; Antipsychotic Agents; Brain; Chromatography, High Pressure Liquid; Fluoxetine; Fluvoxamine; Male; Microsomes, Liver; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Thioridazine

1999
Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    The American journal of psychiatry, 1999, Volume: 156, Issue:9

    Topics: Adolescent; Adult; Aged; Ambulatory Care; Clomipramine; Comorbidity; Controlled Clinical Trials as Topic; Factor Analysis, Statistical; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Personality Inventory; Placebo Effect; Placebos; Probability; Psychiatric Status Rating Scales; Regression Analysis; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tic Disorders; Treatment Outcome

1999
Excretion of paroxetine into breast milk.
    The Journal of clinical psychiatry, 1999, Volume: 60, Issue:8

    Topics: Adult; Breast Feeding; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Humans; Lactation; Milk, Human; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Triglycerides

1999
Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms.
    European journal of pharmacology, 1999, Oct-15, Volume: 382, Issue:3

    Topics: Animals; Blood Glucose; Enzyme Inhibitors; Fenclonine; Fluoxetine; Fluvoxamine; Hyperglycemia; Insulin; Male; Maprotiline; Mice; Selective Serotonin Reuptake Inhibitors; Time Factors

1999
Determination of fluoxetine, fluvoxamine, and clomipramine in pharmaceutical formulations by capillary gas chromatography.
    Journal of chromatographic science, 2000, Volume: 38, Issue:5

    Topics: Chromatography, Gas; Clomipramine; Drug Stability; Fluoxetine; Fluvoxamine; Pharmaceutical Preparations; Quality Control; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Solutions; Temperature

2000
Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography.
    Therapeutic drug monitoring, 2000, Volume: 22, Issue:3

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluorometry; Fluoxetine; Fluvoxamine; Humans; Linear Models; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline

2000
Application of chrome azurol S for the extractive spectrophotometric determination of fluoxetine and fluvoxamine.
    Journal of pharmaceutical and biomedical analysis, 2000, Aug-15, Volume: 23, Issue:2-3

    Topics: Fluoxetine; Fluvoxamine; Hydroxybenzoates; Pharmaceutical Preparations; Selective Serotonin Reuptake Inhibitors; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet

2000
Investigation and analytical application of the reactions of eriochrome cyanine R with fluvoxamine and fluoxetine.
    Journal of pharmaceutical and biomedical analysis, 2000, Aug-15, Volume: 23, Issue:2-3

    Topics: Benzenesulfonates; Coloring Agents; Fluoxetine; Fluvoxamine; Selective Serotonin Reuptake Inhibitors; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet

2000
Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2000, Volume: 23, Issue:4

    Topics: Adult; Aged; Brain; Depressive Disorder, Major; Female; Fluorine Radioisotopes; Fluoxetine; Fluvoxamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors

2000
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
    Drug metabolism and disposition: the biological fate of chemicals, 2000, Volume: 28, Issue:10

    Topics: Antibodies; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Biotransformation; Bupropion; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Isoenzymes; Kinetics; Microsomes, Liver; Oxidoreductases, N-Demethylating; Paroxetine; Piperazines; Sertraline; Triazoles

2000
Determination of four selective serotonin reuptake inhibitors by capillary isotachophoresis.
    Electrophoresis, 2000, Volume: 21, Issue:14

    Topics: Citalopram; Electrophoresis, Capillary; Fluoxetine; Fluvoxamine; Selective Serotonin Reuptake Inhibitors; Sertraline

2000
Chronic fluoxetine administration to juvenile rats prevents age-associated dendritic spine proliferation in hippocampus.
    Brain research, 2000, Nov-17, Volume: 883, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Animals; Cell Count; Dendrites; Desipramine; Fluoxetine; Fluvoxamine; Hippocampus; Male; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors

2000
Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures.
    Clinical therapeutics, 2001, Volume: 23, Issue:2

    Topics: Adult; Antidepressive Agents; Cross-Sectional Studies; Drug Costs; Fluoxetine; Fluvoxamine; Forecasting; Humans; Insurance Claim Reporting; Insurance, Pharmaceutical Services; Middle Aged; Models, Theoretical; Ontario; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

2001
Comparison of noradrenergic and serotonergic antidepressants in reducing immobility time in the tail suspension test.
    Japanese journal of pharmacology, 2001, Volume: 85, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Desipramine; Fluoxetine; Fluvoxamine; Male; Models, Animal; Nortriptyline; Rats; Rats, Inbred Strains; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission; Tail

2001
The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat.
    The Journal of pharmacy and pharmacology, 2001, Volume: 53, Issue:4

    Topics: Animals; Brain; Dopamine Antagonists; Drug Interactions; Fluoxetine; Fluvoxamine; Infusions, Parenteral; Male; Perazine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline

2001
Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine.
    The International journal of eating disorders, 2001, Volume: 30, Issue:1

    Topics: Adolescent; Feeding and Eating Disorders; Fluoxetine; Fluvoxamine; Humans; Male; Prader-Willi Syndrome; Selective Serotonin Reuptake Inhibitors

2001
[The transfer of selective serotonin reuptake inhibitors to human milk].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2001, Jan-20, Volume: 121, Issue:2

    Topics: Antidepressive Agents; Breast Feeding; Citalopram; Depression, Postpartum; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Milk, Human; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

2001
Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire international, 1999, Volume: 8, Issue:43

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Child; Child, Preschool; Clinical Trials as Topic; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1999
The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain.
    British journal of pharmacology, 2001, Volume: 134, Issue:1

    Topics: Animals; Binding, Competitive; Body Temperature; Brain; Cerebral Cortex; Fluoxetine; Fluvoxamine; Indoles; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Nerve Endings; Neuroprotective Agents; Paroxetine; Rats; Rectum; Serotonin; Serotonin Agents; Time Factors; Tritium

2001
Physical exercise: an adjunctive treatment for panic disorder?
    European psychiatry : the journal of the Association of European Psychiatrists, 2001, Volume: 16, Issue:6

    Topics: Adult; Combined Modality Therapy; Exercise; Female; Fluoxetine; Fluvoxamine; Humans; Middle Aged; Panic Disorder; Psychotherapy; Treatment Outcome

2001
Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
    The American journal of psychiatry, 2002, Volume: 159, Issue:5

    Topics: Adolescent; Adult; Age Factors; Autistic Disorder; Brain; Brain Chemistry; Child; Child Development Disorders, Pervasive; Depressive Disorder; Dose-Response Relationship, Drug; Fluorine; Fluoxetine; Fluvoxamine; Half-Life; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors

2002
Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Psychopharmacology, 2002, Volume: 162, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Behavior, Animal; Binding, Competitive; Brain Chemistry; Conditioning, Psychological; Cyclopropanes; Dose-Response Relationship, Drug; Fear; Fluoxetine; Fluvoxamine; Imipramine; Male; Maprotiline; Microdialysis; Milnacipran; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Prefrontal Cortex; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cell Surface; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming; Synaptosomes; Time Factors

2002
Photoisomerization of fluvoxamine generates an isomer that has reduced activity on the 5-hydroxytryptamine transporter and does not affect cell proliferation.
    European journal of pharmacology, 2002, Aug-30, Volume: 450, Issue:3

    Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Brain; Cell Division; Cells, Cultured; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Drug Stability; Fluoxetine; Fluvoxamine; In Vitro Techniques; Male; Photochemistry; Rats; Rats, Sprague-Dawley; Serotonin; Stereoisomerism; Synaptosomes; Ultraviolet Rays

2002
Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
    Brain research, 2002, Dec-20, Volume: 958, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Animals; Brain; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Fluoxetine; Fluvoxamine; Male; Maprotiline; Mice; Motor Activity; Neurons; Norepinephrine; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Synaptic Transmission

2002
Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center.
    Psychiatric services (Washington, D.C.), 2003, Volume: 54, Issue:2

    Topics: Citalopram; Clinical Pharmacy Information Systems; Cost Control; Cost Savings; Drug Administration Schedule; Drug Costs; Drug Utilization; Fluoxetine; Fluvoxamine; Hospital Costs; Hospitals, Veterans; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States

2003
Drug-related hyperprolactinemia.
    Prescrire international, 2003, Volume: 12, Issue:63

    Topics: Antidepressive Agents; Antipsychotic Agents; Female; Flunarizine; Fluoxetine; Fluvoxamine; Humans; Hyperprolactinemia; Indoramin; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sulpiride

2003
Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens.
    Neuropharmacology, 2003, Volume: 44, Issue:3

    Topics: Animals; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Fluvoxamine; Injections, Intraperitoneal; Male; Microdialysis; Motor Activity; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors

2003
Possible involvement of peripheral serotonin 5-HT3 receptors in fluvoxamine-induced emesis in Suncus murinus.
    The Journal of pharmacy and pharmacology, 2003, Volume: 55, Issue:2

    Topics: Animals; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Male; Selective Serotonin Reuptake Inhibitors; Shrews; Vomiting

2003
Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac).
    British journal of pharmacology, 2003, Volume: 138, Issue:6

    Topics: Animals; Brain; Dose-Response Relationship, Drug; Ethanol; Female; Fluoxetine; Fluvoxamine; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Heart; Mice; Potassium Channels; Potassium Channels, Inwardly Rectifying; RNA, Messenger; Xenopus laevis; Zimeldine

2003
Study and analytical application of ion-pair formation in the system fluoxetine-pyrocatechol violet and fluvoxamine-pyrocatechol violet.
    Die Pharmazie, 2003, Volume: 58, Issue:4

    Topics: Albumins; Antidepressive Agents, Second-Generation; Benzenesulfonates; Coloring Agents; Fluoxetine; Fluvoxamine; Indicators and Reagents; Magnetic Resonance Spectroscopy; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tablets

2003
Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice.
    Pharmacology, biochemistry, and behavior, 2003, Volume: 75, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Blood Glucose; Body Weight; Desipramine; Diabetes Mellitus, Experimental; Diazepam; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Hindlimb Suspension; Male; Mice; Mice, Inbred ICR; Motor Activity; Selective Serotonin Reuptake Inhibitors

2003
An interaction between carbamazepine and fluvoxamine.
    British journal of clinical pharmacology, 1993, Volume: 36, Issue:6

    Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Carbamazepine; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Humans; Middle Aged

1993
Serotonin uptake and metabolism by cultured guinea pig airway smooth muscle cells.
    Pulmonary pharmacology & therapeutics, 2004, Volume: 17, Issue:1

    Topics: Animals; Cells, Cultured; Clomipramine; Fluoxetine; Fluvoxamine; Guinea Pigs; Muscle, Smooth; Selective Serotonin Reuptake Inhibitors; Serotonin; Trachea

2004
Different effects of selective serotonin reuptake inhibitors on a patient suffering from panic disorder.
    Human psychopharmacology, 2004, Volume: 19, Issue:1

    Topics: Adult; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Hypnotics and Sedatives; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors

2004
Long-term sequestration of fluorinated compounds in tissues after fluvoxamine or fluoxetine treatment: a fluorine magnetic resonance spectroscopy study in vivo.
    Magma (New York, N.Y.), 2004, Volume: 16, Issue:6

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bone Marrow; Brain; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Female; Fluorine Radioisotopes; Fluoxetine; Fluvoxamine; Humans; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Selective Serotonin Reuptake Inhibitors; Time Factors

2004
Neonatal complications after intrauterine exposure to SSRI antidepressants.
    Prescrire international, 2004, Volume: 13, Issue:71

    Topics: Antidepressive Agents; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; France; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline

2004
Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:5

    Topics: Activities of Daily Living; Acute Disease; Ambulatory Care; Cost-Benefit Analysis; Cyclohexanols; Decision Support Techniques; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Costs; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

2004
Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia.
    Environmental toxicology and chemistry, 2004, Volume: 23, Issue:9

    Topics: Animals; Citalopram; Cladocera; Ecosystem; Female; Fluoxetine; Fluvoxamine; Lethal Dose 50; Male; No-Observed-Adverse-Effect Level; Paroxetine; Reproduction; Selective Serotonin Reuptake Inhibitors; Sertraline; Toxicity Tests, Acute; Toxicity Tests, Chronic; Water Pollutants, Chemical

2004
In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.
    Life sciences, 2004, Oct-29, Volume: 75, Issue:24

    Topics: Analysis of Variance; Animals; Area Under Curve; Binding Sites; Brain; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Paroxetine; Radioligand Assay; Receptors, Serotonin; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Tritium

2004
A sensitive HPLC method for the determination of fluoxetine and norfluoxetine in human plasma with fluorescence detection.
    Therapeutic drug monitoring, 2005, Volume: 27, Issue:1

    Topics: Administration, Oral; Area Under Curve; Benzofurans; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Monitoring; Fluoxetine; Fluvoxamine; Half-Life; Hexanes; Humans; Kinetics; Reference Standards; Sensitivity and Specificity

2005
Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    British journal of pharmacology, 2005, Volume: 144, Issue:5

    Topics: Animals; Behavior, Animal; Binding Sites; Brain; Fluoxetine; Fluvoxamine; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred ICR; Motor Activity; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline

2005
Patients with obsessive-compulsive disorder (OCD) displayed cognitive deficits consistent with a dysfunction of the dorsolateral-striatal circuit.
    Psychological medicine, 2004, Volume: 34, Issue:7

    Topics: Cognition Disorders; Corpus Striatum; Fluoxetine; Fluvoxamine; Frontal Lobe; Humans; Nerve Net; Neuropsychological Tests; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2004
Serotonin and its antidepressant-sensitive transport in mouse cumulus-oocyte complexes and early embryos.
    Biology of reproduction, 2005, Volume: 73, Issue:2

    Topics: Animals; Antidepressive Agents, Second-Generation; Blastocyst; Cell Communication; Cricetinae; Female; Fluoxetine; Fluvoxamine; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Nerve Tissue Proteins; Oocytes; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tryptophan Hydroxylase

2005
Depression in general clinical practice.
    Journal of the Indian Medical Association, 2004, Volume: 102, Issue:10

    Topics: Age Factors; Aged; Antidepressive Agents; Citalopram; Depression; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Risk Factors; Treatment Outcome

2004
(+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 314, Issue:3

    Topics: Animals; Aorta; Fluoxetine; Fluvoxamine; Ketanserin; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Norfenfluramine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tryptophan Hydroxylase; Vasoconstriction

2005
Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
    Analytical and bioanalytical chemistry, 2005, Volume: 382, Issue:6

    Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Solid Phase Microextraction; Venlafaxine Hydrochloride

2005
Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors.
    Regulatory toxicology and pharmacology : RTP, 2005, Volume: 42, Issue:3

    Topics: Environmental Exposure; European Union; Fluoxetine; Fluvoxamine; Forecasting; Humans; Models, Theoretical; Selective Serotonin Reuptake Inhibitors; Sertraline; United States; Water Pollutants, Chemical

2005
Approach to novel functional foods for stress control 4. Regulation of serotonin transporter by food factors.
    The journal of medical investigation : JMI, 2005, Volume: 52 Suppl

    Topics: Animals; Anthracenes; Biflavonoids; Bridged Bicyclo Compounds; Carrier Proteins; Cell Differentiation; Cell Line; Cell Lineage; Cells, Cultured; Fluoxetine; Fluvoxamine; Food; Hypericum; Ligands; Macrophages; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Osteoclasts; Perylene; Phloroglucinol; Plant Extracts; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Recombinant Proteins; Serotonin; Stress, Physiological; Terpenes; Time Factors

2005
From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2006, Volume: 16, Issue:6

    Topics: Analgesics; Animals; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Pain Measurement; Selective Serotonin Reuptake Inhibitors

2006
The spermicidal and antitrichomonas activities of SSRI antidepressants.
    Bioorganic & medicinal chemistry letters, 2006, May-01, Volume: 16, Issue:9

    Topics: Animals; Antidepressive Agents; Antitrichomonal Agents; Drug Evaluation, Preclinical; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Male; Molecular Structure; Selective Serotonin Reuptake Inhibitors; Sertraline; Spermatocidal Agents; Spermatozoa; Structure-Activity Relationship; Trichomonas vaginalis

2006
Cognitive behavioral therapy versus psychosurgery for refractory obsessive-compulsive disorder.
    The Journal of neuropsychiatry and clinical neurosciences, 2006,Winter, Volume: 18, Issue:1

    Topics: Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Gyrus Cinguli; Humans; Middle Aged; Obsessive-Compulsive Disorder; Outcome Assessment, Health Care; Psychosurgery

2006
Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway.
    Journal of chromatography. A, 2006, May-19, Volume: 1115, Issue:1-2

    Topics: Calibration; Chemical Fractionation; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Fluvoxamine; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sewage; Water Pollutants, Chemical

2006
Toxicity and hazard of selective serotonin reuptake inhibitor antidepressants fluoxetine, fluvoxamine, and sertraline to algae.
    Ecotoxicology and environmental safety, 2007, Volume: 67, Issue:1

    Topics: Biomass; Chlorella vulgaris; Dose-Response Relationship, Drug; Eukaryota; Fluoxetine; Fluvoxamine; Phytoplankton; Risk Assessment; Scenedesmus; Selective Serotonin Reuptake Inhibitors; Sertraline; Species Specificity; Structure-Activity Relationship; Time Factors; Water Pollutants, Chemical

2007
Decision-making functioning as a predictor of treatment outcome in anorexia nervosa.
    Psychiatry research, 2006, Dec-07, Volume: 145, Issue:2-3

    Topics: Adult; Anorexia Nervosa; Body Mass Index; Cognition Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Decision Making; Demography; Female; Fluoxetine; Fluvoxamine; Gambling; Humans; Interview, Psychological; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome

2006
Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat.
    Psychopharmacology, 2007, Volume: 190, Issue:1

    Topics: Animals; Antidepressive Agents, Second-Generation; Arachidonic Acid; Brain; Cytosol; Fluoxetine; Fluvoxamine; Frontal Lobe; Injections, Intraperitoneal; Male; Phospholipases A; Phospholipids; Rats; Rats, Inbred F344; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Up-Regulation

2007
Saturable uptake of lipophilic amine drugs into isolated hepatocytes: mechanisms and consequences for quantitative clearance prediction.
    Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:8

    Topics: Algorithms; Amines; Animals; Biological Transport; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Dextromethorphan; Fluoxetine; Fluvoxamine; Hepatocytes; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Imipramine; In Vitro Techniques; Kinetics; Male; Models, Biological; Propranolol; Quinine; Rats; Rats, Sprague-Dawley

2007
Use of isolated hepatocyte preparations for cytochrome P450 inhibition studies: comparison with microsomes for Ki determination.
    Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:11

    Topics: Animals; Catalysis; Cells, Cultured; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dextromethorphan; Enzyme Inhibitors; Fluconazole; Fluoxetine; Fluvoxamine; Hepatocytes; Ketoconazole; Kinetics; Male; Miconazole; Microsomes, Liver; Midazolam; Phenytoin; Quinine; Rats; Rats, Sprague-Dawley; Tolbutamide

2007
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
    The Journal of clinical psychiatry, 2007, Volume: 68, Issue:10

    Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride

2007
Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy.
    The journal of sexual medicine, 2008, Volume: 5, Issue:2

    Topics: Antidepressive Agents; Coitus; Data Interpretation, Statistical; Ejaculation; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Mirtazapine; Models, Biological; Piperazines; Reaction Time; Research Design; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sexual Dysfunction, Physiological; Treatment Outcome; Triazoles

2008
Quality assessment of fluoxetine and fluvoxamine pharmaceutical formulations purchased in different countries or via the Internet by 19F and 2D DOSY 1H NMR.
    Journal of pharmaceutical and biomedical analysis, 2008, Mar-13, Volume: 46, Issue:4

    Topics: beta-Cyclodextrins; Chemistry, Pharmaceutical; Fluoxetine; Fluvoxamine; Humans; Internet; Magnetic Resonance Spectroscopy

2008
Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding.
    European journal of pharmacology, 2008, Sep-11, Volume: 592, Issue:1-3

    Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depression; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred ICR; Motor Activity; Norepinephrine Plasma Membrane Transport Proteins; Serotonin Plasma Membrane Transport Proteins; Species Specificity; Swimming

2008
Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin.
    Biological psychiatry, 2009, May-01, Volume: 65, Issue:9

    Topics: Animals; Drugs, Chinese Herbal; Eating; Fenfluramine; Fluoxetine; Fluvoxamine; Gastrointestinal Motility; Ghrelin; Growth Hormone; Injections, Intraventricular; Male; Oligopeptides; Paroxetine; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Receptors, Ghrelin; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists

2009
Inhibitory effect of selective serotonin reuptake inhibitors on the vesicular monoamine transporter 2.
    Neuroscience letters, 2009, May-01, Volume: 454, Issue:3

    Topics: Animals; Dopamine; Fluoxetine; Fluvoxamine; Haloperidol; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Rats; Rats, Wistar; Reserpine; Selective Serotonin Reuptake Inhibitors; Synaptic Vesicles; Vesicular Monoamine Transport Proteins

2009
Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
    Neuroscience research, 2009, Volume: 64, Issue:3

    Topics: Adenosine Deaminase; Amitriptyline; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Arginine; Cyclopropanes; Desipramine; Fluoxetine; Fluvoxamine; Glutamine; HeLa Cells; Humans; Imipramine; Milnacipran; Morpholines; Paroxetine; Reboxetine; Receptors, AMPA; RNA Editing; RNA-Binding Proteins; RNA, Messenger

2009
Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder.
    Journal of affective disorders, 2010, Volume: 121, Issue:1-2

    Topics: Adult; Clomipramine; Connecticut; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Personality Inventory; Prognosis; Psychometrics; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2010
Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Pediatrics, 2010, Volume: 125, Issue:5

    Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Cohort Studies; Cross-Sectional Studies; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Suicide Prevention; Suicide, Attempted

2010
Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.
    Archives of general psychiatry, 2010, Volume: 67, Issue:5

    Topics: Adult; Aged; Antidepressive Agents; British Columbia; Cause of Death; Citalopram; Cohort Studies; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Hospitalization; Humans; Male; Middle Aged; Paroxetine; Proportional Hazards Models; Risk; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted

2010
Neonatal exposure to fluoxetine and fluvoxamine alteres spine density in mouse hippocampal CA1 pyramidal neurons.
    International journal of clinical and experimental pathology, 2011, Jan-05, Volume: 4, Issue:2

    Topics: Animals; Animals, Newborn; Behavior, Animal; Brain; Dendrites; Exploratory Behavior; Fluoxetine; Fluvoxamine; Male; Mice; Mice, Transgenic; Motor Activity; Pyramidal Cells; Selective Serotonin Reuptake Inhibitors

2011
Long-term follow-up of hypochondriasis after selective serotonin reuptake inhibitor treatment.
    Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:3

    Topics: Adolescent; Adult; Aged; Child Abuse; Clinical Trials as Topic; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Hypochondriasis; Male; Middle Aged; Personality Disorders; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index

2011
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2011, Nov-08, Volume: 183, Issue:16

    Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Canada; Citalopram; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Heart Failure; Hemorrhage; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Neoplasms; Paroxetine; Peptic Ulcer; Platelet Aggregation Inhibitors; Renal Insufficiency; Retrospective Studies; Risk; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Ticlopidine

2011
Treatment practices in Tourette syndrome: the European perspective.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2012, Volume: 16, Issue:4

    Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome

2012
Mechanisms of action of selective serotonin reuptake inhibitors in Daphnia magna.
    Environmental science & technology, 2012, Mar-06, Volume: 46, Issue:5

    Topics: Animals; Body Size; Carbohydrate Metabolism; Cyproheptadine; Daphnia; Female; Fluoxetine; Fluvoxamine; Humans; Life Cycle Stages; Lipid Metabolism; Oxygen Consumption; Proteins; Reproduction; Selective Serotonin Reuptake Inhibitors; Survival Analysis; Water Pollutants, Chemical

2012
Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia.
    The Journal of clinical psychiatry, 2012, Volume: 73, Issue:11

    Topics: Adult; Antipsychotic Agents; Aryl Hydrocarbon Hydroxylases; Clomipramine; Clozapine; Comorbidity; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Schizophrenia; Selective Serotonin Reuptake Inhibitors

2012
Photoassisted defluorination of fluorinated substrates and pharmaceuticals by a wide bandgap metal oxide in aqueous media.
    Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2013, Volume: 12, Issue:5

    Topics: Fluorides; Fluoxetine; Fluvoxamine; Gallium; Halogenation; Hydrogen-Ion Concentration; Kinetics; Oxidation-Reduction; Photolysis; Toluene; Ultraviolet Rays; Water

2013
The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis.
    Paediatric drugs, 2013, Volume: 15, Issue:4

    Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents; Canada; Child; Child, Preschool; Citalopram; Databases, Factual; Fluoxetine; Fluvoxamine; Humans; Infant; Mental Disorders; Paroxetine; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Sertraline

2013
Identification of metabolic pathways in Daphnia magna explaining hormetic effects of selective serotonin reuptake inhibitors and 4-nonylphenol using transcriptomic and phenotypic responses.
    Environmental science & technology, 2013, Aug-20, Volume: 47, Issue:16

    Topics: Animals; Daphnia; Female; Fluoxetine; Fluvoxamine; Hormesis; Oligonucleotide Array Sequence Analysis; Phenols; Phenotype; Selective Serotonin Reuptake Inhibitors; Transcriptome

2013
Therapeutic Drug Monitoring of Selective Serotonin Reuptake Inhibitors in Elderly Patients.
    Therapeutic drug monitoring, 2015, Volume: 37, Issue:4

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Child; Citalopram; Databases, Factual; Drug Monitoring; Drug Utilization; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult

2015
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
    Journal of affective disorders, 2015, Jul-15, Volume: 180

    Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2015
Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay.
    Toxicology in vitro : an international journal published in association with BIBRA, 2015, Volume: 29, Issue:7

    Topics: Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Citalopram; Estradiol; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Progesterone; Selective Serotonin Reuptake Inhibitors; Sertraline; Testosterone

2015
Endogenous 5-HT outflow from chicken aorta by 5-HT uptake inhibitors and amphetamine derivatives.
    The Journal of veterinary medical science, 2016, Volume: 78, Issue:1

    Topics: Animals; Aorta, Thoracic; Chickens; Clomipramine; Fluoxetine; Fluvoxamine; In Vitro Techniques; Male; Methamphetamine; p-Chloroamphetamine; Selective Serotonin Reuptake Inhibitors; Serotonin

2016
Parallel artificial liquid membrane extraction as an efficient tool for removal of phospholipids from human plasma.
    Journal of pharmaceutical and biomedical analysis, 2016, Sep-10, Volume: 129

    Topics: Chromatography, Liquid; Fluoxetine; Fluvoxamine; Humans; Lysophosphatidylcholines; Membranes, Artificial; Pharmaceutical Preparations; Phosphatidylcholines; Phospholipids; Plasma; Quetiapine Fumarate; Sphingomyelins; Tandem Mass Spectrometry; Technology, Pharmaceutical

2016
Pediatric ingestion of vilazodone compared to other selective serotonin reuptake inhibitor medications.
    Clinical toxicology (Philadelphia, Pa.), 2017, Volume: 55, Issue:5

    Topics: Child; Child, Preschool; Citalopram; Coma; Dose-Response Relationship, Drug; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Hospitalization; Humans; Infant; Male; Paroxetine; Poison Control Centers; Retrospective Studies; Seizures; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Vilazodone Hydrochloride

2017
Effects of the antidepressants desipramine and fluvoxamine on latency to immobility and duration of immobility in the forced swim test in adult male C57BL/6J mice.
    Behavioural pharmacology, 2018, Volume: 29, Issue:5

    Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Depression; Desipramine; Disease Models, Animal; Fluoxetine; Fluvoxamine; Immobilization; Male; Mice; Mice, Inbred C57BL; Motor Activity; Swimming

2018
Influence of photolabile pharmaceuticals on the photodegradation and toxicity of fluoxetine and fluvoxamine.
    Environmental science and pollution research international, 2018, Volume: 25, Issue:7

    Topics: Ciliophora; Fluoxetine; Fluvoxamine; Humic Substances; Photolysis; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical

2018
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
    Journal of the American Society of Nephrology : JASN, 2019, Volume: 30, Issue:4

    Topics: Age Factors; Aged; Aged, 80 and over; Cardiac Conduction System Disease; Citalopram; Death, Sudden, Cardiac; Depression; Electrocardiography; Female; Fluoxetine; Fluvoxamine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peroxidase; Registries; Renal Dialysis; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States

2019
Antidepressant treatment strategy with an early onset of action improves the clinical outcome in patients with major depressive disorder and high anxiety: a multicenter and 6-week follow-up study.
    Chinese medical journal, 2020, Mar-20, Issue:6

    Topics: Antidepressive Agents; Anxiety; Citalopram; Depressive Disorder, Major; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Least-Squares Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2020
Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.
    JAMA network open, 2021, 11-01, Volume: 4, Issue:11

    Topics: Adult; Aged; Antidepressive Agents; Citalopram; COVID-19; Cytokines; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Prescription Drugs; Retrospective Studies; Risk; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; United States

2021
Do the Selective Serotonin Reuptake Inhibitor Antidepressants Fluoxetine and Fluvoxamine Reduce Mortality Among Patients With COVID-19?
    JAMA network open, 2021, 11-01, Volume: 4, Issue:11

    Topics: Antidepressive Agents; COVID-19 Drug Treatment; Fluoxetine; Fluvoxamine; Humans; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors

2021
The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2022, 10-19, Volume: 37, Issue:11

    Topics: Case-Control Studies; Citalopram; Cohort Studies; Death, Sudden, Cardiac; Dialysis Solutions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Potassium; Renal Dialysis; Selective Serotonin Reuptake Inhibitors; Sertraline; United States

2022
Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths.
    Journal of affective disorders, 2022, 12-01, Volume: 318

    Topics: Adolescent; Antipsychotic Agents; Citalopram; Diabetes Mellitus, Type 2; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline

2022
SSRIs differentially modulate the effects of pro-inflammatory stimulation on hippocampal plasticity and memory via sigma 1 receptors and neurosteroids.
    Translational psychiatry, 2023, 02-03, Volume: 13, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; COVID-19; Drug Inverse Agonism; Fluoxetine; Fluvoxamine; Hippocampus; Lipopolysaccharides; Neurosteroids; Rats; Selective Serotonin Reuptake Inhibitors

2023
Effects of CYP2C19 inhibitors on mavacamten pharmacokinetics in rats based on UPLC-MS/MS.
    Chemico-biological interactions, 2023, Aug-01, Volume: 380

    Topics: Animals; Chromatography, High Pressure Liquid; Chromatography, Liquid; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Fluconazole; Fluoxetine; Fluvoxamine; Humans; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tandem Mass Spectrometry

2023
Treatment-Resistant Depression (TRD): Is the Opioid System Involved?
    International journal of molecular sciences, 2023, Jul-06, Volume: 24, Issue:13

    Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Mianserin; Mice; Mirtazapine; Moclobemide; Naloxone; Reboxetine; Trazodone; Venlafaxine Hydrochloride

2023
Pharmacological profile of antidepressants and related compounds at human monoamine transporters.
    European journal of pharmacology, 1997, Dec-11, Volume: 340, Issue:2-3

    Topics: Antidepressive Agents; Brain; Carrier Proteins; Cell Line; Dopamine Plasma Membrane Transport Proteins; Humans; In Vitro Techniques; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Radioligand Assay; Serotonin Plasma Membrane Transport Proteins; Symporters; Synaptosomes

1997